APT Medical Inc. (SHA:688617)

Market Cap	43.64B
Revenue (ttm)	2.28B
Net Income (ttm)	755.75M
Shares Out	141.01M
EPS (ttm)	5.35
PE Ratio	57.81
Forward PE	48.85
Dividend	1.21 (0.39%)
Ex-Dividend Date	Jun 19, 2025

Volume	1,759,706
Average Volume	1,807,444
Open	304.30
Previous Close	303.91
Day's Range	304.30 - 316.60
52-Week Range	215.92 - 331.03
Beta	-0.32
RSI	62.29
Earnings Date	Aug 22, 2025

About APT Medical

APT Medical Inc. engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China. The company offers electrophysiological products comprising mapping catheters, ablation catheters, transseptal needle and sheaths, and steerable sheaths; and interventional cardiology and peripheral intervention products, such as introducer kits, guiding extension catheters, balloon catheters, guiding catheters, microcatheters, guidewires, hydrophilic angiographic catheters, hydrophilic guid...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 2,555
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688617

Financial Performance

In 2024, APT Medical's revenue was 2.07 billion, an increase of 25.18% compared to the previous year's 1.65 billion. Earnings were 673.15 million, an increase of 26.08%.